More on ZVSA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/14/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ZyVersa Therapeutics (NQ:ZVSA)
Delayed: 0.31 --0 (-0%)
Prev. Close $0.31  
Open$0.31 
52 Wk High$ 
52 Wk Low$ 
Day High$0.31 
Day Low$0.31 
P/E N/A  
EPS$ 
Volume27,018 

Friends, Peers and Foes (?): , ARBB, BNOX, CAT, DFS (more...)

Mar 5, 2026 04:06 PM Form 8-K ZyVersa Therapeutics, For: Feb 27
Dec 3, 2025 04:16 PM Form 8-K ZyVersa Therapeutics, For: Dec 02
Nov 19, 2025 04:26 PM Form 8-K ZyVersa Therapeutics, For: Nov 19
Nov 19, 2025 04:17 PM Form 10-Q ZyVersa Therapeutics, For: Sep 30
Nov 14, 2025 05:02 PM Form NT 10-Q ZyVersa Therapeutics, For: Sep 30
Oct 15, 2025 04:30 PM Form 8-K ZyVersa Therapeutics, For: Oct 10
Oct 6, 2025 02:19 PM Form 25-NSE ZyVersa Therapeutics, Filed by: Nasdaq Stock Market LLC
Sep 18, 2025 07:01 AM Form 8-K ZyVersa Therapeutics, For: Sep 14
Aug 14, 2025 09:26 PM Form SCHEDULE 13G/A ZyVersa Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Aug 14, 2025 07:55 AM ZyVersa begins phase 2a trial for diabetic kidney disease treatment
View All Articles

Entities mentioned with ZVSA

View All Entities